Exchange of views with the Alliance for Regenerative Medicine on the implementation of the HTA Regulation as well as the reform of the EU Pharmaceutical Legislation. (Lobbyradar DE, 2026)
Daten unter CC-BY-SA 4.0; Quellen siehe Detailseite.